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Abstract  25 
 26 
Atlantic salmon (Salmo salar) were fed 6 experimental diets containing three levels of 27 
arachidonic acid (ARA) (0.18, 0.28 and 0.63 % for low, medium and high levels 28 
respectively) and two levels of vitamin E (150 and 730 mg kg-1 for low and high levels 29 
respectively). At the end of the experimental period, fatty acids in the liver and 30 
immunity markers (lysozyme activity, respiratory burst and phagocytic activity) were 31 
determined and fish subjected to a challenge test against the salmonid ricketsial 32 
syndrome (SRS) pathogen. ARA, vitamin E or their interaction did not exert an effect 33 
on fish performance, whereas ARA alone clearly increased the deposition of ARA. 34 
Dietary vitamin E only enhanced liver vitamin E deposition, while the interaction of 35 
ARA and vitamin E influenced lysozyme activity and EPA/ARA ratio pointing out the 36 
effect of both nutrients on the fish immune system and metabolism. Only the medium 37 
concentration contributed to reducing mortality when the fish were exposed to the SRS 38 
pathogen. In conclusion, different levels of supplementation with ARA and vitamin E in 39 
the diet had no effect on productivity, but did have effects on immune markers and 40 
cumulative mortality when fish were exposed to the SRS pathogen. 41 
 42 
43 
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Introduction 44 
 45 
With the growth of the aquaculture industry, more attention has been paid to fish 46 
welfare and health in order to avoid negative impacts on fish performance and 47 
consequently economic losses. Use of properly balanced diets seems to be a feasible 48 
approach for allowing fish to have improved immunological response and thus greater 49 
ability to cope with disease. Although the role of lipids in immune function in fish has 50 
been studied, the results are not always conclusive because their effect apparently 51 
depends on environmental conditions, the genetic status of the studied organism as well 52 
as the interaction among different types of fatty acids and other nutrients (Montero et al. 53 
1999; Kiron et al. 2004; Bureau et al. 2008).  54 
 55 
It is known that lipids, in addition to being an excellent source of energy and a vehicle 56 
for fat soluble vitamins, are the source of polyunsaturated fatty acids (PUFA) such as 57 
di-homo-gamma-linolenic acid (DHGLA; 20:3n-6), arachidonic acid (ARA; 20:4n-6) 58 
and eicosapentaenoic acid (EPA; 20:5n-3), which are the precursors of two groups of 59 
eicosanoids: those derived from the cyclooxygenase action such as prostaglandins (PG) 60 
and thromboxanes (TX) and those derived from the lipoxygenase action such as 61 
lipoxins (LX) and leukotrienes (LT) (Bell et al. 1995). These compounds are part of the 62 
defence systems of the organisms and therefore play a role in certain pathophysiological 63 
processes such as resistance to stress stimuli, the immune response and inflammatory 64 
processes (Lall 2000). It has been stated that depending on the type of the individual 65 
fatty acids, their concentrations and the relationships among them, eicosanoids can have 66 
pro- or anti-inflammatory effects. Therefore, diets rich in n-6 fatty acids, primarily 67 
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ARA, produce pro-inflammatory effects derived from higher levels of PGE2, LT4 and 68 
LX, whereas diets high in n-3 PUFAs, particularly EPA, produce anti-inflammatory 69 
effects derived from PGE3 and LT5 (Lall 2000). Although overproduction of PGE2 due 70 
to high dietary ARA can also have an immunosuppressant effect (Bell et al. 1996), this 71 
effect can be mitigated depending on the concentrations of EPA and DHGLA given that 72 
both fatty acids have an inhibitory effect on ARA. Because ARA is generally the 73 
preferred substrate of lipoxygenases for LT synthesis (Bell et al. 1994) and products 74 
derived from these enzymes produce stronger immune stimulatory effects than those 75 
derived from cyclooxygenases (Hwang 1989), one would expect that incorporating 76 
ARA into the diet would contribute to an improved immune response in fish and 77 
therefore increased resistance against attack from pathogens. Thus, n-6 fatty acids play 78 
an important role in inflammatory processes, stimulating the production of pro-79 
inflammatory cytokines such as the tumour necrosis factor-alpha (TNF-α) and 80 
interleukins (IL) 1 and 6 and consequently leading to pro-inflammatory events such as 81 
vasodilation and increased vascular permeability (Calder 2002). 82 
 83 
Although anadromous teleost fish such as rainbow trout (Oncorhynchus mykiss) and 84 
Atlantic salmon (Salmo salar) have the ability to elongate and desaturate short-chain 85 
fatty acids to long chain PUFA (LC-PUFA) in their fresh water phase and their 86 
requirements can be satisfied by fatty acids such as linoleic acid (LA; 18:2n-6) and α-87 
linolenic acid (LNA; 18:3n-3) (Bell & Sargent 2003), it is not clear whether these fatty 88 
acids are sufficient for maintaining fish in adequate physiological condition. Thus, 89 
supplementation with LC-PUFA, such as ARA, EPA and docosahexaenoic acid (DHA; 90 
22:6n-3) is always appropriate and recommended. Furthermore, Bell et al. (2003) 91 
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suggested the potential impact of ARA in restoring normal immune function in 92 
freshwater fish fed low-ARA diets despite of their ability to synthesize LA to ARA. 93 
Thus, the use of feeds with an unadjusted n-6/n-3 fatty acids ratio, mainly ARA, can 94 
alter the fish immune system and resilience when exposed to pathogens. 95 
 96 
Given that PUFAs are susceptible to oxidation due to their high unsaturation degree, 97 
and that oxidation products can be toxic to fish, the high levels of these fatty acids in 98 
aquafeeds need to be accompanied by adequate amounts of dietary antioxidants. Among 99 
them, vitamin E (α-tocopherol) is a powerful antioxidant that is commonly included in 100 
feeds formulation as a form of protection against fatty acid oxidation (Kiron et al. 2004; 101 
Betancor et al. 2011; Hamre 2011). In addition, vitamin E can improve the fish immune 102 
response as this nutrient is involved in preventing lipid peroxidation of cell membranes, 103 
the regulation of the specific immunity, nonspecific resistance factors and disease 104 
resistance capacity (Sahoo & Mukherjee 2002). The relationships among LC-PUFA, 105 
vitamin E and the immune response have been studied in rainbow trout (Kiron et al. 106 
2004; Puangkaew et al. 2004, 2005; Trenzado et al. 2009), Japanese flounder 107 
(Paralichthys olivaceus) (Wang et al. 2006) and gilthead seabream (Sparus aurata) 108 
(Montero et al. 2004). However most of these studies have not evaluated the effect of 109 
the LC-PUFA/vitamin E ratio when fish are challenged against pathogens, and 110 
furthermore, no studies have linked an increase of specific dietary fatty acids (such as 111 
ARA) with vitamin E requirements. However, there is evidence that vitamin E 112 
participates in the conversion of ARA into prostaglandins via cyclooxygenase action in 113 
mammals (O’Leary et al. 2004) and similar action could also happen in teleost fish. 114 
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Furthermore, given that ARA is a minor component of fish cell membranes and that is 115 
required in small amounts compared to DHA and EPA, its importance has been 116 
underestimated (Bell et al. 2003; Xu et al. 2010). However, the limited studies on ARA 117 
have suggested an important contribution of this fatty acid fish growth, survival and 118 
bone formation as well as its influence on modulating the immune response and disease 119 
resistance in several teleost fish species (Khozing – Goldberg et al. 2006; Van Anholt et 120 
al. 2004, 2012; Xu et al. 2010; Li et al. 2012; Boglino et al. 2014; Tian et al. 2014). 121 
Nevertheless, there is not enough evidence linking dietary ARA and vitamin E levels in 122 
freshwater fish species. Therefore, it is expected that appropriately balanced 123 
incorporation of this fatty acid with vitamin E could improve processes in which ARA 124 
is involved such as a favourable immune response.  125 
Salmonid rickettsial syndrome (SRS), caused by Piscirickettsia salmonis, is considered 126 
to be the most important sanitary problem in the Chilean salmon farming industry, with 127 
economic losses up to $100 million per year. Thus, the impact of SRS on salmon 128 
farming in Chile could be mitigated by strengthening the immune activity in the fish 129 
through an appropriate balance between dietary ARA and vitamin E. In the present 130 
study, we aimed to elucidate the interaction between ARA and vitamin E on juvenile 131 
Atlantic salmon immune response and their protective effect when fish were challenged 132 
with the causative agent of SRS.  133 
 134 
Materials and methods 135 
 136 
2.1. Experimental fish 137 
 138 
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One thousand five hundred and thirty juvenile Atlantic salmon were obtained from a 139 
local fish farm (Pesquera los Fiordos; commune of Curarrehue, region IX, Chile) and 140 
transferred to the Quimey-Co de Sociedad Nalcahue Ltda. fish farm (commune of 141 
Pucón, Caburga sector, region IX, Chile). The fish were acclimatised for two weeks and 142 
fed a commercial diet (BIOMAR S.A., Chile). Prior to the start of the experimental 143 
trial, the fish were distributed among eighteen 100 L tanks at a ratio of 85 fish tank-1 144 
with an average weight of 6.5 ± 1.1 g to reach an initial density of 5.5 kg m-3. Tanks 145 
had a continuous water supply at a rate of 1.5 L h-1 and fish were maintained under a 24 146 
h light photoperiod, being the water the temperature in tanks 9.9 ± 0.2 ºC and dissolved 147 
oxygen concentrations above 10 mg L-1.  148 
 149 
2.2 Experimental diets and feeding 150 
 151 
Six experimental feeds were formulated and manufactured to contain three dietary 152 
levels of ARA (1.05, 1.73 and 3.73 % for low, medium and high respectively) and two 153 
levels of vitamin E as α-tocopherol acetate (0.12 - 0.19 and 0.72 - 0.76 g kg-1, for low 154 
and high respectively). Feeds were isolipidic and isoproteic, and levels of other fatty 155 
acids held constant. A set of 5 different oils was employed to obtain the desired levels 156 
of ARA altering minimally the levels of other PUFA. In this sense, an ARA-enriched 157 
oil was employed in ARA3 diets, whereas a n-6-rich oil (Yardquim oil) was used in 158 
ARA2 and ARA3 feeds. All the feeds contained n-3-rich oil (ROPUFA® n-3 INF oil) to 159 
help maintain adequate levels on n-3 PUFA as well as olive oil to equalize the fat 160 
content of all the feeds. Finally, the diets containing the lowest ARA levels were 161 
supplemented with an oil rich in EPA (ROPUFA® n-3 EPA oil) to maintain similar 162 
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EPA levels to the other feeds. The diets were labelled as ARA1/E1 (low ARA/low 163 
vitamin E), ARA1/E2 (low ARA/high vitamin E), ARA2/E1 (medium ARA/low 164 
vitamin E), ARA2/E2 (medium ARA/high vitamin E), ARA3/E1 (high ARA/low 165 
Vitamin E) and ARA3/E2 (high ARA/high vitamin E). The diets were formulated and 166 
manufactured in the feed pilot plant of the School of Aquaculture of the Catholic 167 
University of Temuco (Chile) using a CLEXTRAL experimental extruder, model B21 168 
(Firminy Cedex, France), and oiled by a Dinissen vacuum oiler (Pegasus Menger, 400 l, 169 
Sevenum, Holland). Each diet was tested in triplicate for 12 weeks. Fish were fed to 170 
apparent visual satiety, ten times per day by hand, and uneaten feed was removed by 171 
siphoning, dried and weighed to calculate fish feed intake. VEVODAR® (DSM 172 
nutritional products S.A., Puerto Varas, Chile) was used as the source of ARA and 173 
Rovimix E-50® for vitamin E (DSM nutritional products S.A., Puerto Varas, Chile). 174 
The formulation, proximal composition, fatty acid profile and vitamin E concentration 175 
of the diets were analysed in the fish nutrition laboratory of the School of Aquaculture 176 
at the Catholic University of Temuco and are shown in Tables 1 and 2. 177 
 178 
2.3. Productive indicators 179 
The following productive variables were evaluated: 180 
 Increase in weight (%) = [(final weight – initial weight) / initial weight] × 100. 181 
 Feed conversion factor = increase in weight (g)/total food intake (g). 182 
 Specific growth rate (% day-1) = [(ln final weight - ln initial weight) / days] × 183 
100. 184 
 TGC (thermal growth coefficient) = [(final weight1/3 – initial weight1/3) × 1000] / 185 
∑ (temperature × days) 186 
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 Condition index = (final weight / final length3) × 100  187 
 Hepatosomatic index = (liver weight (g) / final weight) × 100  188 
 Protein efficiency ratio = gain in body mass (g) / protein intake (g) 189 
 Percent survival (%) = (Nº final specimens/initial number of specimens) × 100  190 
 191 
2.4. Analysis and measurements  192 
2.4.1. Collection of blood and tissue samples for analysis.  193 
At the end of the experimental period, fish were starved for 24 hours prior to the final 194 
sampling. Six fish per tank (n =18 per treatment) were anesthetized with 20% 195 
benzocaine (BZ-20; Veterquimica S.A., Santiago, Chile) and bled by puncturing the 196 
caudal vein with 1 mL syringes. Blood samples were immediately placed in Eppendorf 197 
tubes containing 5 µL of heparin to prevent blood clotting. The tubes containing blood 198 
were centrifuged at 3500 rpm for 10 minutes at a constant temperature of 4 °C to 199 
separate the plasma from the cells. Fresh plasma was frozen at -80 °C until lysozyme 200 
activity was determined. 201 
Then, fish were sacrificed in 10 L containers with an overdose of benzocaine together 202 
with ice to maintain a temperature of 4 ºC in order to obtain fresh samples. Liver 203 
samples were collected for determination of fatty acids (6 fish tank-1, n = 18 per 204 
treatment), and samples stored at -80 ºC until further analysis. Kidney samples were 205 
also obtained for immune parameters analysis and quickly frozen at -80 °C until further 206 
analysis. 207 
 208 
2.4.2 Total lipids and fatty acid analysis.  209 
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Total lipids were extracted using a chloroform:methanol mixture (2:1) according to the 210 
method by Folch et al. (1957). Fatty acids were methylated according to the method 211 
proposed by Morrisony Smith (1964). Fatty acids were separated using a Hewlett 212 
Packard 5890 series II Plus (Wilmington NC, USA) gas chromatograph with a capillary 213 
column of 30*0.25*0.20 mm (SPTM 2380, SUPELCO, Bellafonte, PA USA). Helium 214 
gas was used as a carrier. Fatty acids were identified by comparison to a SUPELCO 37 215 
fatty acid standard (Sigma Aldrich, St. Louis, MO, USA). Fatty acids are expressed as 216 
percentage of the total fatty acids identified. 217 
 218 
Vitamin E analysis 219 
The free α-tocopherol level of the diets and liver tissues were determined at the Quality 220 
Control Laboratory, DSM Nutritional Products S.A. (Puerto Varas, Los Lagos Region, 221 
Chile), according to the company analytical methods and procedures for vitamins and 222 
carotenoids. Analysis equipment included an HPLC Perkin Elmer series 200 (Shelton, 223 
CT, USA) with auto sampler, a UV-visible detector, a Link interface 600 series data 224 
system recollection "Totalchrom Workstation" version 6.2.1., and a column Lichrosorb 225 
Si 60.5 μm * 25 * 4 mm Alltech brand- Grom (Germany). Briefly, the HPLC conditions 226 
used for the vitamin assessment were as follows: reflux extraction with potassium 227 
hydroxide solution in methanol and continuation with a hexane:toluene (1:1) solution, 228 
room temperature conditions, and a mobile phase with a hexane:dioxane (97:3) solution 229 
injected (20 μL) through an automatic nozzle. The results are expressed as mg kg-1 of 230 
free α-tocopherol. 231 
 232 
2.4.3. Immune parameters  233 
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 234 
 Extraction of leucocytes to determine phagocytosis and respiratory burst 235 
 236 
Leucocytes from the anterior portion of the kidney were used to determine phagocytic 237 
activity and respiratory burst following the method proposed by Sakai et al. (1996). 238 
Leucocytes were extracted from the same specimens used for blood sampling. Kidneys 239 
were aseptically removed and placed in L-15 medium (Sigma, St. Louis, MO, USA) 240 
supplemented with 10% foetal bovine serum, 0.2% heparin (Sigma, St. Louis, MO, 241 
USA) and 0.1% penicillin/streptomycin (Sigma, St. Louis, MO, USA). Maceration was 242 
conducted and the resulting cellular suspension was layered onto a 34/51% Percoll 243 
gradient (Pharmacia, Uppsala, Sweden). After centrifugation, the interphase cells were 244 
isolated, washed in Hanks medium and number adjusted to 107 cells mL-1. Viable 245 
phagocytic cells were quantified by trypan blue exclusion (viability > 95%). 246 
 247 
 Leucocytes respiratory burst activity 248 
 249 
To measure intracellular superoxide anion production, the method developed by Yin et 250 
al. (2006) was used. The leucocyte suspension was distributed into 96-well plates and 251 
the reduction of nitroblue tetrazolium (NBT) was evaluated. Untreated leucocytes were 252 
used as a negative control and leucocytes treated with 0.5 mg mL-1 phorbol myristate 253 
acetate (PMA) were used as a positive control. The cell culture was maintained at 18º C 254 
for 18 h. The extract, PMA treatments and cell monolayer were washed twice with 255 
Hank’s saline solution (HBSS, Sigma). Then, 100 µL of NBT solution (1 mg mL-1 in 256 
RPMI 1640) were added per well and incubated for 60 min at 18º C. After incubation, 257 
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the NBT solution was removed and the cells were fixed with methanol for 10 min. The 258 
cells were air-dried and the formazan in each well was dissolved in 120 µL of 2 M 259 
KOH and 140 µL of dimethyl sulphoxide (Sigma). Optical density was measured with a 260 
Multiscan spectrophotometer (Spectra, Count, Pakard USA) at 630 nm. 261 
 262 
 Phagocytic activity 263 
 264 
The phagocytic activity of the leucocytes was determined by the direct count method, 265 
which involves co-incubating leucocytes isolated from the anterior kidney with yeast 266 
cells stained with Congo red in 96-well plates. The mixtures were incubated at 18 °C for 267 
3 hours and the percentage of leucocytes with phagocytosed cells was counted and 268 
considered a direct measure of the level of immune stimulation of the cells. The counts 269 
involved a total of 15 optical fields in triplicate for each specimen tested. 270 
 271 
 Lysozyme activity  272 
The turbidimetric assay for measuring lysozyme (Parry et al. 1965) was performed in a 273 
96-well plate. A volume of 200 µL of a suspension of Micrococcus lisodeikticus (0.2 274 
mg mL-1 in 50nM sodium phosphate buffer) and 5, 10, 20 or 40 µL of blood plasma 275 
were mixed in different wells, and then absorbance recorded at 520 nm at 1, 3, 6 and 9 276 
min with a microplate reader (Elx808BioTex USA). One unit of activity was defined as 277 
the amount of sample causing a 0.001 min-1 decrease in absorbance. 278 
 279 
2.4.4. Bacterial challenge test 280 
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At the end of the experimental period, 18 specimens per treatment (6 fish per tank) were 281 
transported from the hatchery of the Catholic University of Temuco to the Aquadvise 282 
Experimental Unit of Fundación Chile (Puerto Montt, region X, Chile). Fish were 283 
marked with PIT-tags system (Trovan®, Trovan Ltd., United Kingdom) and placed in a 284 
720 L tank with a turnover rate of 1.2 L h-1. The oxygen concentration was maintained 285 
between 90 and 100% saturation and the water temperature at 14.5 ºC. The temperature 286 
was higher because the SRS challenge model requires 14.5 to 15 ºC to develop optimum 287 
pathogen replication in the fish. The acclimatisation period lasted 6 days, after which 288 
the fish were challenged by intraperitoneal injection using a strain of Piscirickettsia 289 
salmonis (SRS) as a salmonid pathogen at a dose of 0.2 mL SRS per fish at a 10-2 290 
dilution considering previous LD50 results. During the SRS challenge, all the fish of the 291 
same treatment were kept in the same tank. The inoculum was provided by the 292 
“Fundación Ciencia para la Vida” (Science for Life Foundation). To verify the cause of 293 
death, head kidney of deceased fish were analysed by the direct immunofluorescence 294 
technique SRS FluoroTest Direct (Bios Chile, Santiago, Chile) wherein monoclonal 295 
antibodies are conjugated to fluorescein isothiocyanate (FITC). This test is highly 296 
sensitive and specific for detecting Piscirickettsia salmonis in tissue samples (Marshall 297 
et al., 2007).  298 
 299 
 300 
2.5 Statistical analysis.  301 
The results were statistically analysed using a two-factor ANOVA after prior 302 
confirmation of theoretical assumptions of data normality through histograms and 303 
homogeneity of variances by Bartlett’s test. Once these theoretical assumptions were 304 
satisfied, analyses of variance were performed to determine significant differences 305 
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among the treatments at the 95% confidence level. If there were differences, Duncan’s 306 
test was then used to differentiate the means among the three different ARA levels, 307 
revealing those treatments that exhibited significant differences (Sokal & Rohlf 1995). 308 
For vitamin E levels, a student t-test was employed to denote significant differences 309 
between the two vitamin levels. The arcsine transformation was applied to data 310 
expressed as percentages to achieve homoscedasticity. The statistical software MS 311 
STATISTICA 12 was used in the statistical analyses. 312 
 313 
Results 314 
 315 
3.1. Growth and dietary utilisation. 316 
Fish growth in terms of final weight did not differ (P>0.05) among the different 317 
experimental groups or their replicates. All fish groups increased their weight up to 318 
three times relative to initial weight, reaching an average value between 21.8 and 23.9g. 319 
The specific growth rate (SGR) varied between 1.27 and 1.37% per day. The 320 
conversion factor rate (CF) was similar among the experimental diets, ranging from 321 
1.01 to 1.13. Hepatosomatic index (HSI) values were within the normal range (0.95 to 322 
1.11) without showing significant differences (P>0.05). None of the evaluated 323 
performance parameters showed significant differences (P>0.05) when subjected to 324 
statistical analysis (Table 3).  325 
 326 
3.2 Liver fatty acids and vitamin E contents 327 
Table 4 shows the fatty acid composition and measured vitamin E content in the liver of 328 
juvenile Atlantic salmon fed the six dietary treatments. The levels of vitamin E 329 
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concentrations in the liver were directly proportional to its dietary incorporation, and 330 
higher (P<0.05) in the high vitamin E group. Fish fed diets containing a high 331 
concentration of ARA showed significantly higher (P<0.05) accumulation of this fatty 332 
acid than fish fed low and medium levels of ARA, together with a reduction in the 333 
EPA/ARA ratios (Table 4). Besides, there was no interaction between the two nutrients, 334 
ARA concentration did not affect (P>0.05) the vitamin E concentration in liver tissue 335 
and vitamin E dietary levels did not affect (P>0.05) the ARA content in the tissue. The 336 
only interaction between both nutrients was found in the EPA/ARA ratios (P<0.05; 337 
Table 4), whereas ARA levels did affect C14, total monounsaturated, EPA, DHA 338 
(P<0.005), as well as ARA (P<0.01) percentages according to the two-way ANOVA 339 
performed. 340 
 341 
3.3 Fish health: Immune parameters and challenge test. 342 
 343 
No significant differences (P>0.05) or interactions between ARA and vitamin E were 344 
found for phagocytic activity in fish fed any of the dietary treatments (Table 5). 345 
However, a significant effect (P<0.05) of vitamin E was found on lysozyme activity, 346 
with the group fed ARA2/E1 displaying significantly (P<0.05) higher lysozyme 347 
enzymatic activity (Table 5), although no differences were observed with fish fed 348 
ARA3/E2. Besides, ARA levels significantly (P<0.05) affected leucocyte respiratory 349 
burst activity with the lowest (P<0.05) activity corresponding to fish fed the lowest 350 
ARA level (Table 5). Furthermore, an interaction between ARA and vitamin E levels 351 
was observed in lysozyme activity (P<0.01; Table 5), whereas individual ARA did exert 352 
an effect on the leucocytes respiratory burst (P<0.01; Table 5). 353 
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 354 
Regardless of the level of dietary vitamin E, fish fed diets containing low concentrations 355 
of ARA displayed cumulative mortality between 56 and 65% when exposed to the SRS 356 
pathogen (Fig. 1). In all cases where the concentration of ARA in the diet was low or 357 
high, cumulative mortality was below 50%. However, when the ARA concentration in 358 
the diet was medium and the vitamin E concentration was high, higher survival rates 359 
were achieved. It was determined that 100% of the recorded mortality was confirmed 360 
for the presence of the SRS pathogen.  361 
 362 
Discussion  363 
Despite of the relevance of vitamin E, studies assessing its relationship with PUFA, 364 
particularly ARA, and how this relationship may affect fish growth are scarce. In the 365 
present study 6 different experimental feeds containing two levels of vitamin E and 366 
three levels of ARA were fed to Atlantic salmon to evaluate the single effect of these 367 
nutrients as well as their interaction on fish performance, liver composition and 368 
immunological response after challenge with SRS. ARA and vitamin E supplementation 369 
did not affect the growth of juvenile Atlantic salmon in terms of length or weight, 370 
showing that there was no independent or synergistic effect between the two nutrients 371 
on fish performance. This indicates that low dietary concentrations of ARA (circa 1% of 372 
the total fatty acids) and vitamin E (circa 150 mg kg-1) were sufficient for supporting 373 
adequate fish growth. These results are in line with previous studies where increases in 374 
ARA levels over 12 times in terms of total fatty acids together with constant levels of 375 
vitamin E did not enhance any of the studied growth performance parameters in Atlantic 376 
salmon post-smolts (Glencross et al. 2014). 377 
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 378 
EPA, ARA and DHGLA are fatty acids precursors of eicosanoids via the actions of 379 
lipoxygenases and cyclooxygenases. It is known that eicosanoids derived from ARA, 380 
mainly LTB4 and PGE2, are pro-inflammatory, whereas those derived from EPA and 381 
DHGLA have an anti-inflammatory action (Hwang 1989). Thus it is expected that 382 
altering the EPA/ARA ratio in cell membranes may alter the production of eicosanoids 383 
and modulate the inflammatory response (Bell et al. 1995). Some studies have shown 384 
that ARA is the preferred precursor for the synthesis of eicosanoids in fish, competing 385 
with EPA (Bell et al. 1994). In the present study, the changes in liver fatty acid 386 
composition largely reflected that of the diets, showing variations in the ARA contents, 387 
which were increased with increasing ARA dietary levels. Although in the present study 388 
only fatty acids from total lipids were determined, a previous study in Atlantic salmon 389 
showed that the ARA content of phospholipids fatty acids of several tissues was 390 
correlated to the ARA dietary intake (Betancor et al. 2014). Thus, taking into account 391 
that the percentage of neutral and polar lipids in Atlantic salmon fed fish oil-profile diet 392 
is around 30 and 60% respectively (Torstensen et al. 2004), a considerable amount of 393 
ARA will be available in the Atlantic salmon membranes for its bioconversion to 394 
reactive eicosanoids.  395 
Furthermore, dietary ARA influenced the deposition of other fatty acids such as oleic 396 
acid (18:1n-9), EPA and DHA. It must be noted that liver is considered an important 397 
site for LC-PUFA synthesis and lipid metabolism in Atlantic salmon (Monroig et al. 398 
2010). Hepatic levels of ARA did not differ between fish fed low and medium ARA 399 
levels which could be attributed to enhanced biosynthesis from 18:2n-6. Besides, as the 400 
same Δ6 and Δ5 –desaturase and fatty acyl elongase enzymes participate in the synthesis 401 
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of both the n-3 and n-6 LC-PUFA (Zheng et al. 2005), the activation of one pathway 402 
could also enhance the final and intermediate products of the other, what could account 403 
for the increased EPA and DHA contents found in low ARA-fed fish. Enhanced 404 
conversion from 18:2n-6 to 20:3n-6 was greater than for 18:4n-3 to 20:4n-3 in Atlantic 405 
salmon fed diets devoid of n-3 LC-PUFA, which resulted in significantly higher 406 
concentrations of ARA in liver (Miller et al. 2008). 407 
Dietary ARA also elicited an effect in leucocytes respiratory activity, medium and high 408 
levels leading to up-regulation of the respiratory burst activity. However ARA did not 409 
trigger an effect on any of the other health-related parameters, which could indicate that 410 
up-regulation of burst activity alone is not sufficient to enhance bactericidal activity 411 
against SRS by Atlantic salmon leucocytes. Similarly, yeast β-glucans, known to have 412 
an immune stimulatory effect in fish (Magnadóttir 2006) only elicited macrophages 413 
respiratory burst, not eliciting any effect on bactericidal activity (Jørgensen and 414 
Robertsen, 1995) 415 
Low levels of ARA combined with high or low levels of vitamin E lead to low 416 
concentrations of ARA in the liver, low stimulation of macrophages as well as 417 
cumulative mortality between 56 and 65% from the SRS pathogen. Thus an increase in 418 
vitamin E did not contribute to stimulate the immune response in the presence of low 419 
levels of ARA, nor improved the response against the SRS pathogen as indicated by the 420 
two-way ANOVA analysis. Blazer & Wolke (1984) found that T and B lymphocytes 421 
function in rainbow trout was suppressed under vitamin E deficiency and that this 422 
vitamin requirement may increase during immune stimulation. Furthermore, a 423 
combination of medium levels of ARA with high or low levels of vitamin E not only 424 
improved macrophage activity but also allowed better resistance to the pathogen SRS, 425 
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decreasing mortality by 40% and 24%, respectively. Accordingly, a reduction in 426 
vitamin E concentration in the diet to near 200 mg kg-1 can contribute to maintaining an 427 
active immune response provided that ARA is maintained at medium levels. In turn, 428 
when the ARA concentration in the diet is high, its concentration in liver tissue 429 
increases, the immune response remains high and mortality against the pathogen is 430 
maintained only between 45 and 50% regardless of the vitamin E level in the diet. 431 
Generally, an increase in ARA in cell membranes enhances the availability of ARA as a 432 
substrate for eicosanoid production, resulting in greater availability of PGE2 (Bell & 433 
Sargent 2003), which has been shown to have immune stimulatory effects, directly 434 
influencing macrophage action (Montero et al. 1996). Evidence that ARA incorporation 435 
in the diet improves nonspecific immunity has been recently shown in carp 436 
(Ctenopharyngodon idellus) and in yellow croaker (Larimichthys crocea) (Tian et al. 437 
2014; Xu et al. 2014), however none of these studies have monitored indicators of 438 
immunity in response to combined ARA and vitamin E or how this is reflected when 439 
fish are exposed to a specific pathogen.  440 
According to the results of the present study, vitamin E and ARA act synergistically to 441 
stimulate lysozyme activity particularly with medium concentrations of ARA and low 442 
concentrations of vitamin E. Similarly, high macrophage activity was observed as 443 
improved resistance to the pathogen SRS only when ARA was present at a medium 444 
concentration in the diet. Thus high supplementation of vitamin E is unnecessary for 445 
immune stimulation when dietary ARA level is medium or high. This coincides with the 446 
finding of Pungkaew et al. (2005), who suggested that high supplementation of vitamin 447 
E is not necessary for proper immune stimulation when the level of PUFA is adequate, 448 
although these authors did not expose fish to a pathogen which would allow immune 449 
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response to be evaluated. Curiously, the EPA/ARA ratio was also affected by the 450 
interaction of ARA and vitamin E contents. A relationship between vitamin E and LC-451 
PUFA levels has been described in several fish species (Mourente et al., 2007; Lebold 452 
et al., 2011), hypothesizing that tocopherols may influence the biosynthesis of PUFA, 453 
especially n-3 PUFA, through alteration of cellular oxidation potential or peroxide tone. 454 
 455 
In summary, inclusion of ARA in Atlantic salmon feeds improved some indicators of 456 
non-specific immunity such as respiratory burst, being this effect independent of the 457 
vitamin E concentration. ARA inclusion also seemed to elicit an effect on LC-PUFA 458 
biosynthesis by enhancing EPA and DHA levels in fish fed low ARA feeds. Medium 459 
inclusion of ARA combined with a high concentration of vitamin E was found to reduce 460 
cumulative mortality by 65%. An interaction between ARA and vitamin E was observed 461 
on lysozime activity and EPA/ARA ratio probably indicating and effect of vitamin E on 462 
LC-PUFA biosynthesis. To conclude, the interactive effect between vitamin E and ARA 463 
was shown to be limited, although each nutrient, particularly ARA, proved to exert a 464 
marked effect on Atlantic salmon immune response.  465 
 466 
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Figure legends 685 
Figure 1. Effect of dietary ARA/Vitamin E content on the cumulative mortality of 686 
Atlantic salmon (Salmo salar) juveniles after challenge test with Piscirickettsia 687 
salmonis (SRS) at a dose of 0.2 mL SRS fish-1 at a 10-2 dilution. 688 
 689 
 690 
 691 
692 
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Table 1. Formulation of experimental diets 693 
Ingredients (g kg-1 diet) ARA1/E1 ARA1/E2 ARA2/E1 ARA2/E2 ARA3/E1 ARA3/E2 
       
Fish meala  619 618 626 625 621 620 
Feather mealb 50 50 50 50 50 50 
Corn Glutenc 40 40 40 40 40 40 
Wheat meald 140 140 140 140 140 140 
Astaxantine 1 1 1 1 1 1 
Vitamin premixf 2 2 2 2 2 2 
Mineral premixg 5 5 5 5 5 5 
Olive oil h 50 50 50 50 40 40 
Vevodar ® ARA oil i  - - - - 15 15 
Yardquim oilj  - - 21 21 21 21 
ROPUFA® n-3 INF oilk  83 83 65 65 65 65 
ROPUFA® n-3 EPA oill  10 10 - - - - 
Vitamin E (α-tocopherol)m 0.015 0.65 0.015 0.65 0.015 0.65 
aSupplied by  Alimentos Marinos (ALIMAR) S.A. Jack mackerel meal, Super Prime 694 
(Protein 68%, Lipids 9.9%, Ashes 14.5%). 695 
bSupplied by Härting S.A., Santiago, Chile. 696 
cSupplied by BIOMAR Chile S.A., Puerto Montt, Chile. 697 
dSupplied by Molinos Gorbea S.A., Gorbea, Chile. 698 
eSupplied by DSM Nutritional Product Chile S.A, Puerto Varas, Chile.  699 
fSupplied by DSM Nutritional Product Chile S.A. (IU/kg or g/kg of premix): Vitamin A 700 
1.0 MIU; Vitamin D3, 0.5 MIU; Vitamin E, 0.04 MIU; Vitamin K 3. 4 g; Vitamin  B1, 701 
4 g; Vitamin B2, 6 g; Vitamin B5, 10 g;  Vitamin B6, 2 g; Vitamin B9, 1.6 g; Vitamin 702 
B12, 0.00 4g; Niacin, 40 g; Biotin, 0.1 g; Vitamin C 100 g; Choline, 200 g; Inositol 50 703 
g. 704 
gSupplied by BIOMAR Chile  S.A (per g mixture: mg; Cu: 8.3 mg; Mn: 67 mg; Co: 1.7 705 
mg; y: 1.7; Zn: 200 mg) 706 
hCarbonell, Spain (SAFA: 17.00 MUFA: 73.16; PUFA n-3: 0.00; PUFA n-6: 8.65). 707 
iSupplied by  DSM Food Specialities (SAFA: 34.16; MUFA : 11.89; n-3 PUFA: 2.62; 708 
n-6; 51.33) 709 
jSupplied by Yardas División Química LTDA (SAFA: 6.30; MUFA: 25.43; PUFA n-3: 710 
55.68; PUFA n-6: 12.59). 711 
kSupplied by DSM Food Specialties (SAFA: 40.71; MUFA: 32.60; n-3 PUFA : 22.98; 712 
n-6 PUFA: 5.60). 713 
lSupplied by DSM Nutritional Product Chile S.A. (SAFA: 38.80; MUFA: 32.60; n-3 714 
PUFA: 22.98; n-6 PUFA :5.60). 715 
mSupplied by DSM Nutritional Product Chile S.A. Rovimix E-50 (1g is equivalent to 716 
500 mg of α-tocopherol acetate) 717 
 718 
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Table 2. Chemical (g kg-1) and fatty acids (% of total fatty acid identified) composition 720 
of the experimental diets. 721 
 ARA1/E1 ARA1/E2 ARA2/E1 ARA2/E2 ARA3/E1 ARA3/E2 
       
Proximal composition  
Protein (N × 6.25) 553  553  558  556  556  558  
Nitrogen free 
extract 
120  117  118  122  121  114  
Ash 102  102  102  102  102  102  
Lipid  219  220  215  213  216  220  
α-tocopherol 
acetate 
0.12 0.76 0.19  0.73 0.19 0.72 
Fatty acid 
composition  
      
C14:0 3.91  3.57  3.02  3.10  3.16  3.05  
C15:0 0.58  0.43  0.45  0.46  0.46  0.45  
C16:0 21.81  21.24  18.16  18.42  18.95  18.45  
C17:0 0.97  0.90  0.83 0.82  0.85  0.82  
C18:0 4.29  4.01  4.11  4.14  4.46  4.46  
C20:0 0.27  0.26  0.33  0.32  0.33  0.34  
C21:0 0.91  0.71  0.63  0.56 0.87 0.75  
C22:0 0.08  0.08  0.13  0.13  0.33  0.33  
C24:0 0.29  0.27  0.26  0.27  0.30  0.31  
Total SAFA  33.11  31.46  27.91  28.23  29.71  28.96  
       
C16:1 n-7 4.80  4.39  3.88  3.98  3.92  3.79  
C18:1 n-9 22.10  20.66  21.63  21.83  19.94  19.31  
C20:1 n-9 0.83  0.76  3.17  3.11  2.58  3.06  
C22:1 n-9 0.13  0.13  0.86  0.73 0.61  0.91  
C24:1 n-9 0.59  0.52  1.01  1.00  0.83  0.98  
Total MUFA  28.45  26.47  30.55  30.65  27.89  28.06  
       
C18:2 n-6 6.80  6.36  6.09 6.15 6.36 6.19 
C18:3 n-3 0.68  0.63  0.63  0.64 0.60  0.60  
C18:3 n-6 0.15  0.14  0.10  0.14 0.35  0.34  
C20:4 n-6 1.05  1.06  1.77  1.73 3.73  3.75  
C20:5 n-3 10.16  10.43  12.21  12.55 11.44  12.21 
C22:2 n-6 0.09  0.10  0.05  0.04  0.04  0.04  
C22:6 n-3  16.23  16.04 19.11 19.40 17.89 18.87 
Total PUFA 35.17  34.77  39.96  40.66 40.42  42.00  
EPA/ARA 9.64 9.86 6.91 7.27 3.06 3.26 
 722 
SAFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, 723 
polyunsaturated fatty acids; EPA, eicosapentaenoic acid; ARA, arachidonic acid. 724 
 725 
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Table 3.  Growth, feed, utilization and survival in Atlantic salmon (Salmo salar L.) fed 727 
the experimental diets  728 
 729 
Paramete
rs 
ARA1/
E1 
ARA1/
E2 
ARA2/
E1 
ARA2/
E2 
ARA3/
E1 
ARA3/
E2 
AR
A 
Vit
E 
ARAxV
itE 
Final 
weight 
(g) 
23.3 ± 
0.9 
22.8 ± 
0.4 
23.9 ± 
1.4 
23.8 ± 
1.9 
21.8 ± 
0.6 
22.4 ± 
1.3 
ns ns ns 
Feed 
consumpt
ion 
(%BW 
day-1)b 
1.33 ± 
0.0 
1.29 ± 
0.0 
1.30 ± 
0.1 
1.29 ± 
0.1 
1.38 ± 
0.0 
1.28 ± 
0.0 
ns ns ns 
FCRc 
1.07 ± 
0.0 
1.03 ± 
0.1 
1.02 ± 
0.1 
1.01 ± 
0.1 
1.13 ± 
0.0 
1.03 ± 
0.1 
ns ns ns 
SGR (% 
day-1)d 
1.34 ± 
0.0 
1.32 ± 
0.0 
1.37 ± 
0.1 
1.36 ± 
0.1 
1.27 ± 
0.0 
1.30 ± 
0.1 
ns ns ns 
TGC (% 
day-1)e 
1.03 ± 
0.0 
1.01 ± 
0.0 
1.06 ± 
0.1 
1.05 ± 
0.1 
0.97 ± 
0.0 
0.99 ± 
0.1 
ns ns ns 
Kf 
1.10 ± 
0.0 
1.09 ± 
0.1 
1.12 ± 
0.1 
1.03 ± 
0.0 
1.09 ± 
0.1 
1.09 ± 
0.1 
ns ns ns 
HSIg 
1.04 ± 
0.1 
0.98 ± 
0.1 
0.95 ± 
0.0 
1.06 ± 
0.2 
1.02 ± 
0.0 
1.11 ± 
0.1 
ns ns ns 
PERh 
1.70 ± 
0.0 
1.76 ± 
0.0 
1.76 ± 
0.2 
1.78 ± 
0.1 
1.59 ± 
0.0 
1.74 ± 
0.1 
ns ns ns 
Survival 
(%) 
98.4 ± 
2.7 
98.8 ± 
1.2 
98.8 ± 
1.2 
99.2 ± 
0.7 
98.4 ± 
1.8 
99.6 ± 
0.7 
ns ns ns 
 730 
Values are expressed as mean ±SD (n=3), ns : no significant effect (P> 0,05) 731 
aWeight gain(%): [(final weight – initial weight) / initial weight]×100. 732 
bFeed consumption (%Body weight/day): 100 × [(consumed feed / final weight/2 + 733 
initial weight/ 2) /days]. 734 
 cFCR (feed convertion ratio): weight gain (g) / total feed consumed (g). 735 
dSGR (Specific growth rate): [(Ln. final weight - Ln. initial weight) / days]×100. 736 
eTGC (Thermal growth coefficient): [(final weight1/3 – initial weight1/3) × 1000] / ∑ 737 
(temperature × days). 738 
fK (Condition factor): (final weight / final length 3) × 100  739 
gHSI (hepatosomatic index): (liver weight(g) / final weight) × 100  740 
hPER (protein efficiency ratio): gain in body mass (g) / protein intake (g) 741 
 742 
743 
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Table 4. Free alpha - tocopherol content (mg kg-1 of tissue) and fatty acid profile (% of 744 
total fatty acid identified) in liver of Salmo salar after being fed with the six 745 
experimental diets during 12 weeks. 746 
 747 
 748 
Values are expressed as mean + SD (n= 3 replicates). ARA1/E1, low ARA/low vitamin 749 
E; ARA1/E2, low ARA/high vitamin E; ARA2/E1, medium ARA/low vitamin ; 750 
ARA2/E2, medium ARA/high vitamin E; ARA3/E1, high ARA/low Vitamin E; 751 
ARA3/E2, high ARA/high vitamin E. #Significantly different from liver of fish fed low 752 
dietary vitamin E based on a student t-test. Different superscript letters within an 753 
individual row denote significant statistical differences in fatty acid content according to 754 
Duncan’s post-hoc test. Asterisks indicate significant differences as *P<0.05; 755 
**P<0.001; n.s. indicates non-significant differences. SAFA, saturated fatty acids; 756 
MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; EPA, 757 
eicosapentaenoic acid; ARA, arachidonic acid. 758 
 759 
760 
 
Experimental diets 
 p-value (two-way 
ANOVA) 
 ARA1/E1 ARA1/E2 ARA2/E1 ARA2/E2 ARA3/E1 ARA3/E2  ARA VitE ARA*VitE 
α-tocopherol acetate 
5.1 ± 0.1 
224.0 ± 
109.7# 
15.1 ± 8.2 
209.9 ± 
17.4# 
10.7 ± 1.6 
90.2 ± 
9.5# 
 ns ** ns 
Fatty acid composition           
C14:0 1.4 ± 0.0 1.4 ± 0.1 1.5 ± 0.0 1.5 ± 0.1 1.4 ± 0.1 1.5 ± 0.0  * ns ns 
C15:0 0.5 ± 0.0 0.4 ± 0.1 0.4 ±0.0 0.4 ± 0.0 0.4 ± 0.0 0.4 ± 0.0  ns ns ns 
C16:0 22.5 ± 0.5 20.6 ± 2.3 21.4 ± 0.0 21.2 ± 0.2 21.8 ± 0.2 21.5 ± 0.4  ns ns ns 
C17:0 0.9 ±0.0 0.9 ± 0.1 0.9 ± 0.1 0.9 ± 0.0 0.9 ± 0.0 0.9 ± 0.0  ns ns ns 
C18:0 4.7 ± 0.0 4.5 ± 0.6 4.5 ± 0.2 4.9 ± 0.2 4.8 ± 0.1 5.1 ± 0.1  ns ns ns 
C21:0 0.3 ± 0.0 0.3 ± 0.0 0.3± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0  ns ns ns 
C22:0 0.2 ± 0.0 0.2± 0.0 0.2± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.3± 0.1  ns ns ns 
Total SAFA 30.5 ± 
0.69 
28.2 ± 2.9 29.2 ± 0.2 29.3 ± 0.3 29.8 ± 0.2 30.1 ± 0.3  ns ns ns 
C16:1 n-7 1.6 ± 0.0 1.8± 0.1 1.7 ± 0.1 1.6 ± 0.1 1.6 ± 0.1 1.7 ± 0.1  ns ns ns 
C18:1 n-9 11.3 ± 
0.4b 
12.5 ± 
0.3ab 
12.7 ± 
0.7a 
12.8 ± 
0.8a 
11.7 ± 
0.1b 
11.0 ± 
0.8b 
 * ns ns 
C20:1 n-9 0.5 ± 0.1 0.6 ± 0.1 0.7 ± 0.0 0.6 ± 0.1 0.6 ± 0.0 0.6 ± 0.1  ns ns ns 
C24:1 n-9 0.6 ± 0.0 0.9 ± 0.3 0.9 ± 0.0 0.9 ± 0.2 0.7 ± 0.2 0.8 ± 0.1  ns ns ns 
Total MUFA 14.0 ± 
0.6b 
15.8 ± 
0.7ab 
16.0 ± 
0.8a 
16.0 ± 
1.0a 
14.7 ± 
0.0b 
14.9 ± 
1.0b 
 * ns ns 
C18:2 n-6 2.6 ± 0.0 2.6 ± 0.0 2.6 ± 0.1 2.7 ± 0.1 2.8 ± 0.0 2.6 ± 0.0  ns ns ns 
C18:3n-3 0.2 ± 0.0 0.2 ± 0.0 0.3 ± 0.0 0.2 ± 0.0 0.1 ± 0.0 0.2 ±0.0  ns ns ns 
C20:2  0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0  ns ns ns 
C20:4 n-6 3.3 ± 0.2a 3.3 ± 0.1a 2.9 ± 
0.21a 
3.3 ± 0.2a 6.2 ± 0.2b 5.7 ± 0.6b  ** ns ns 
C20:5 n-3 5.8 ± 0.1a 5.9 ± 0.1a 6.2 ± 0.1a 6.1 ± 0.1a 5.1 ± 0.1b 5.6 ± 
0.6ab 
 * ns ns 
C22:6 n-3 42.8 ± 
0.7a 
43.1 ± 
2.7a 
41.6 ± 
1.3b 
41.2 ± 
0.8b 
40.6 ± 
0.6b 
39.8 ± 
1.0b 
 * ns ns 
Total PUFA 55.0 ± 0.7 55.4 ± 2.8 54.0 ± 1.3 54.0 ± 0.6 55.2 ± 0.1 54.5 ± 1.0  ns ns ns 
EPA/ARA 1.7 ± 0.1b 1.8 ± 0.0b 2.2 ± 0.2a 1.9 ± 
0.1ab 
0.8 ± 0.0c 1.0 ± 0.2c  * ns * 
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Table 5. Effects of the dietary ARA and vitamin E levels as well as their interaction on 761 
the studied immune parameters. 762 
 763 
 764 
 765 
 766 
 767 
 768 
Asterisks indicate significant differences as **P<0.001; n.s. indicates non-significant 769 
differences 770 
771 
 
ARA1/E1 ARA1/E2 ARA2/E1 ARA2/E2 ARA3/E1 ARA3/E2 
ARA Vit 
E 
ARA*VitE 
Respiratory 
burst 
0.18±0.01a 0.18±0.01a 0.23±0.02b 0.23±0.02b 0.24±0.01b 0.24±0.02b ** ns ns 
Phagocytic 
activity 
19.7±4.5 22.7±5.2 18.6±4.5 16.1±4.9 17.5±4.7 24.0±6.5 ns ns ns 
Lysozyme 
activity 
0.07±0.03a 0.06±0.01a 0.12±0.03b 0.06±0.03a 0.06±0.02a 0.09±0.01a ns ns ** 
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Figure 1. Effect of dietary ARA/Vitamin E content on the cumulative mortality of 772 
Atlantic salmon (Salmo salar) juveniles after challenge test with Piscirickettsia 773 
salmonis (SRS) at a dose of 0.2 mL SRS per fish at a 10-2 dilution. 774 
 775 
 776 
 777 
 778 
 779 
 780 
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